Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

HIV and Hepatitis Virus Infection.

Poles1, Dieterich

  • 1University of California, Los Angeles, Division of Digestive Diseases, Center for the Health Sciences 44-138, 10833 Le Conte Avenue, Los Angeles, CA 90095-1684, USA.

Current Infectious Disease Reports
|November 30, 2000
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Density correlations in lattice gases in contact with a confining wall

Physical review. E, Statistical physics, plasmas, fluids, and related interdisciplinary topics·2000
Same author

High magma storage rates before the 1983 eruption of kilauea, hawaii

Science (New York, N.Y.)·2000
Same author

Heightened odds of large earthquakes near istanbul: An interaction-based probability calculation

Science (New York, N.Y.)·2000
Same author

Thermally activated flux motion in a one-dimensional Josephson-junction array with self-inductances.

Physical review. B, Condensed matter·1996
Same author

Microscopic Explanation of the Non-Arrhenius Conductivity in Glassy Fast Ionic Conductors.

Physical review letters·1996
Same author

Slave-boson study in the SU(2)-invariant representation: Coupled layers in the one-band Hubbard model.

Physical review. B, Condensed matter·1996
Same journal

Chagas Disease: An Opportunistic Infection in AIDS.

Current infectious disease reports·2026
Same journal

Area-based Deprivation Indices and Healthcare-Associated Infections: A Narrative Review of Evidence.

Current infectious disease reports·2025
Same journal

Next Steps: Studying Diabetic Foot Infections with Next-Generation Molecular Assays.

Current infectious disease reports·2024
Same journal

To Tweet or Not to Tweet-a Review of the Viral Power of Twitter for Infectious Diseases.

Current infectious disease reports·2024
Same journal

Web alert.

Current infectious disease reports·2024
Same journal

Bacterial Vaginosis in Postmenopausal Women.

Current infectious disease reports·2023
See all related articles

As people with HIV live longer, managing viral hepatitis coinfections is crucial. Treatment for hepatitis C in HIV patients shows similar effectiveness to those without HIV, and some hepatitis B treatments are also effective.

Area of Science:

  • Infectious Diseases
  • Hepatology
  • Virology

Background:

  • Increasing life expectancy in HIV patients necessitates focus on comorbidities like viral hepatitis.
  • Viral hepatitis incidence is elevated in HIV-infected individuals due to shared risk factors.
  • HIV coinfection impacts viral hepatitis progression differently: worsening hepatitis C but potentially reducing hepatitis B liver damage.

Purpose of the Study:

  • To evaluate the impact of HIV coinfection on viral hepatitis natural history.
  • To assess the efficacy and safety of treating viral hepatitis in HIV-infected patients.
  • To address therapeutic nihilism regarding viral hepatitis treatment in this population.

Main Methods:

  • Review of existing studies on HIV and viral hepatitis coinfection.

Related Experiment Videos

  • Analysis of treatment outcomes for hepatitis C and B in HIV-positive individuals.
  • Comparison of treatment efficacy in HIV-coinfected versus HIV-seronegative patients.

    • Main Results:

    • HIV coinfection adversely affects hepatitis C but may mitigate liver damage in hepatitis B.
    • Hepatitis A, E, and G are not significantly impacted by HIV-related immunosuppression.
    • Treatment of hepatitis C in HIV patients demonstrates comparable efficacy and long-term response to HIV-seronegative individuals.
    • Interferon efficacy is reduced for hepatitis B, but nucleoside analogues show effectiveness.

    Conclusions:

    • Therapeutic nihilism for viral hepatitis in HIV patients is unwarranted.
    • Effective treatment options exist for viral hepatitis coinfections in HIV-positive individuals.
    • Managing viral hepatitis is essential for improving long-term morbidity and mortality in the growing HIV-infected population.